Merrilee A. Needham
Expertise in
5
conditions

Merrilee A. Needham

90 South St, 
Murdoch, WA, AU 
Expertise in
5
conditions
90 South St, 
Murdoch, WA, AU 
OverviewLocationsClinical Research

Overview

Merrilee Needham practices in Murdoch, Australia. Ms. Needham is highly rated in 5 conditions, according to our data. Her top areas of expertise are Inclusion Body Myositis, Myositis, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Gastrostomy.

Her clinical research consists of co-authoring 93 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

90 South St, Murdoch, WA 6150, Australia
Other Locations
11 Robin Warren Drive, Murdoch, WA 6150, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomised Double-Blind Placebo-Controlled Phase 3 Trial of Triumeq in Amyotrophic Lateral Sclerosis
Randomised Double-Blind Placebo-Controlled Phase 3 Trial of Triumeq in Amyotrophic Lateral Sclerosis
Enrollment Status: Terminated
Publish Date: July 11, 2025
Intervention Type: Drug
Study Drug: Dolutegravir, Abacavir and Lamivudine
Study Phase: Phase 3
A Phase 1, Open-Label, Single and Multiple Ascending Dose Study of ABC008 in Adult Patients With Inclusion Body Myositis (IBM)
A Phase 1, Open-Label, Single and Multiple Ascending Dose Study of ABC008 in Adult Patients With Inclusion Body Myositis (IBM)
Enrollment Status: Completed
Publish Date: February 20, 2025
Intervention Type: Drug
Study Drug: ABC008
Study Phase: Phase 1
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
Enrollment Status: Terminated
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: WVE-004
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

93 Total Publications

Expanding the MYOD1 Phenotype: A Case Report of a Patient Diagnosed Whilst Pregnant.
Expanding the MYOD1 Phenotype: A Case Report of a Patient Diagnosed Whilst Pregnant.
Journal: Journal of neuromuscular diseases
Published: June 27, 2022

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Needham's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile